Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial

BACKGROUND: Human immunodeficiency virus (HIV)-related chronic lung disease (CLD) among children is associated with substantial morbidity, despite antiretroviral therapy. This may be a consequence of repeated respiratory tract infections and/or dysregulated immune activation that accompanies HIV inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Martinez, Carmen, Kranzer, Katharina, McHugh, Grace, Corbett, Elizabeth L., Mujuru, Hilda, Nicol, Mark P., Rowland-Jones, Sarah, Rehman, Andrea M., Gutteberg, Tore J., Flaegstad, Trond, Odland, Jon O., Ferrand, Rashida A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745989/
https://www.ncbi.nlm.nih.gov/pubmed/29282143
http://dx.doi.org/10.1186/s13063-017-2344-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745989/
https://www.ncbi.nlm.nih.gov/pubmed/29282143
http://dx.doi.org/10.1186/s13063-017-2344-2

Ejemplares similares